97 related articles for article (PubMed ID: 26901013)
1. Use of MRI in Differentiation of Papillary Renal Cell Carcinoma Subtypes: Qualitative and Quantitative Analysis.
Doshi AM; Ream JM; Kierans AS; Bilbily M; Rusinek H; Huang WC; Chandarana H
AJR Am J Roentgenol; 2016 Mar; 206(3):566-72. PubMed ID: 26901013
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma.
Dilauro M; Quon M; McInnes MD; Vakili M; Chung A; Flood TA; Schieda N
AJR Am J Roentgenol; 2016 Feb; 206(2):319-25. PubMed ID: 26797358
[TBL] [Abstract][Full Text] [Related]
3. Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer.
Chandarana H; Rosenkrantz AB; Mussi TC; Kim S; Ahmad AA; Raj SD; McMenamy J; Melamed J; Babb JS; Kiefer B; Kiraly AP
Radiology; 2012 Dec; 265(3):790-8. PubMed ID: 23175544
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of Papillary Renal Cell Carcinoma Subtypes on MRI: Qualitative and Texture Analysis.
Vendrami CL; Velichko YS; Miller FH; Chatterjee A; Villavicencio CP; Yaghmai V; McCarthy RJ
AJR Am J Roentgenol; 2018 Dec; 211(6):1234-1245. PubMed ID: 30240294
[TBL] [Abstract][Full Text] [Related]
5. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
6. Textural differences in apparent diffusion coefficient between low- and high-stage clear cell renal cell carcinoma.
Kierans AS; Rusinek H; Lee A; Shaikh MB; Triolo M; Huang WC; Chandarana H
AJR Am J Roentgenol; 2014 Dec; 203(6):W637-44. PubMed ID: 25415729
[TBL] [Abstract][Full Text] [Related]
7. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
8. [Differential diagnosis between renal cell carcinoma associated with XP11.2 translocation/TFE gene fusion and papillary renal cell carcinoma based on CT and MRI findings].
Zhu Q; Zhu W; Wu J; Fu J; Chen W; Wang Z
Zhonghua Yi Xue Za Zhi; 2014 May; 94(19):1470-2. PubMed ID: 25143166
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI.
Egbert ND; Caoili EM; Cohan RH; Davenport MS; Francis IR; Kunju LP; Ellis JH
AJR Am J Roentgenol; 2013 Aug; 201(2):347-55. PubMed ID: 23883215
[TBL] [Abstract][Full Text] [Related]
10. Differentiation between papillary renal cell carcinoma and fat-poor angiomyolipoma: a preliminary study assessing detection of intratumoral hemorrhage with chemical shift MRI and T2*-weighted gradient echo.
Woo S; Kim SY; Cho JY; Kim SH
Acta Radiol; 2018 May; 59(5):627-634. PubMed ID: 29069911
[TBL] [Abstract][Full Text] [Related]
11. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of subtypes of renal cell carcinoma with contrast-enhanced ultrasonography.
Xue LY; Lu Q; Huang BJ; Li CX; Yan LX; Wang WP
Clin Hemorheol Microcirc; 2016 Oct; 63(4):361-371. PubMed ID: 26598999
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis.
Wang W; Cao K; Jin S; Zhu X; Ding J; Peng W
Eur Radiol; 2020 Oct; 30(10):5738-5747. PubMed ID: 32367419
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
[TBL] [Abstract][Full Text] [Related]
15. Quantitative multiparametric MR analysis of small renal lesions: correlation with surgical pathology.
Yano M; Fowler KJ; Srisuwan S; Salter A; Siegel CL
Abdom Radiol (NY); 2018 Dec; 43(12):3390-3399. PubMed ID: 29691619
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of mult-detector CT for papillary renal cell carcinoma and chromophobe renal cell carcinoma].
Liu X; Zou X; Chen H; Fang X; Hu X; Sun R
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):52-6. PubMed ID: 25877320
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
18. [MR imaging features of different renal cell carcinoma subtypes].
Wu B; Peng WJ; Gu YJ; Yang TX; Jiang ZX; Zhang HL; Dai B; Ye DW; Kong YY; Du X
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):825-30. PubMed ID: 19173827
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]